← Open Payments lookup

REBECCA SMITH: Open Payments

NPI 1396470423 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$394 in 15 payments from 7 companies in 2025. Trend: 2023 $20 · 2024 $14 · 2025 $394

Food & beverage: $304Education: $90
CompanyPaymentsAmount
Janssen Biotech, Inc.3$128
ABBVIE INC.4$89
AstraZeneca Pharmaceuticals LP2$45
MOTIVA USA, LLC2$41
Atland Pharmaceuticals, LLC1$40
PFIZER INC.2$33
UCB, Inc.1$17

Products named: TREMFYA, SKYRIZI, SAPHNELO, Motiva Implant Matrix, RINVOQ, ORPHENADRINE CITRATE, ASPIRIN AND CAFFEINE, XELJANZ, SIMPONI ARIA.

Industry payments across AL — which companies pay providers there.